1.Response: The Association between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Vertebral Fractures in Type 2 Diabetes (Endocrinol Metab 2012;27:289-94, Cheol Ho Lee et al.).
Cheol Ho LEE ; Min Kyung LEE ; Hyun Jeong HAN ; Tae Ho KIM ; Jae Hyuk LEE ; Se Hwa KIM
Endocrinology and Metabolism 2013;28(1):78-79
No abstract available.
Glycosylation End Products, Advanced
2.Letter: The Association between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Vertebral Fractures in Type 2 Diabetes (Endocrinol Metab 2012;27:289-94, Cheol Ho Lee et al.).
Endocrinology and Metabolism 2013;28(1):76-77
No abstract available.
Glycosylation End Products, Advanced
3.Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than N(ε)-(Carboxymethyl) Lysine.
Mami YOKOTA ; Marie SEKITA ; Yuri OKANO ; Hitoshi MASAKI ; Masayoshi TAKEUCHI ; Yoshihiro TOKUDOME
Annals of Dermatology 2017;29(4):508-511
No abstract available.
Glycosylation End Products, Advanced*
;
Lysine*
4.Palliative Care and End-of-Life Care in the Community What Can We Focus on?
Shigeo TOMURA ; Yoshiyuki KIZAWA
Journal of the Japanese Association of Rural Medicine 2008;57(6):851-854
The goal of palliative care is to soothe or relieve the patients with serious illness of their suffering and to improve the quality of their life. It integrates the physical, psychological, social and spiritual aspects of patient care into a comprehensive whole. Doctors and other medical workers talk with the patients by providing appropriate information and explanations and care should be carried out according to the patients' wishes. The care team should confirm their wishes at every opportunity since the patients' wishes can change with time. The presenters who were actually involved in medical care or nursing care discussed how to solve the problems of palliative care and end-of-life care.
End
;
Life
;
Palliative Care
;
Community
;
Doctors
5.Effects of Posttraumatic Hypothermia in an Animal Model of Traumatic Brain Injury(TBI): Immunohistochemical Stain by TUNEL & beta-APP.
Byeong Kil AN ; Young Soo HA ; Dong Keun HYUN ; Chong Oon PARK ; Joon Mee KIM
Journal of Korean Neurosurgical Society 2000;29(4):461-470
No abstract available.
Animals*
;
Brain*
;
Hypothermia*
;
In Situ Nick-End Labeling*
;
Models, Animal*
10.Expert consensus on diagnosis and treatment of end-stage liver disease complicated infection (2021 version).
Chinese Journal of Hepatology 2022;30(2):147-158
End-stage liver disease (ESLD) is a life-threatening clinical syndrome with significantly increased mortality when the patients are complicated with infections. For patients with ESLD, infections can induce or aggravate the liver decompensation. In turn, infections are among the most common complication with the disease progression. Experts from Society of Infectious Diseases, Chinese Medical Association firstly formulated "Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infection" in July 2018, which is extensively revised based on clinical evidence of recent three years. This consensus summarizes the up-to-date knowledge and experiences across Chinese colleagues, intending to provide principles and wording procedures for clinicians to diagnose and treat ESLD patient complicated with infections.
Consensus
;
Disease Progression
;
End Stage Liver Disease/complications*
;
Humans
Result Analysis
Print
Save
E-mail